Droperidol was a first-line, highly effective agent for the treatment of PONV for over 30 years. It has the most postmarketing surveillance data of any of the currently used antiemetic agents. Yet ...

Of the 277 reports, 97 involved at least one cardiac symptom ( Table 1 ). Of those 97 reports, 32 were cases duplicated as many as five times ( Table 2 ), leaving 65 individual cases. Of the ...